Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Net Income (2017 - 2026)

Crinetics Pharmaceuticals has reported Net Income over the past 9 years, most recently at -$122.6 million for Q4 2025.

  • For Q4 2025, Net Income fell 52.16% year-over-year to -$122.6 million; the TTM value through Dec 2025 reached -$465.0 million, down 56.2%, while the annual FY2025 figure was -$465.3 million, 56.18% down from the prior year.
  • Net Income for Q4 2025 was -$122.6 million at Crinetics Pharmaceuticals, up from -$130.1 million in the prior quarter.
  • Over five years, Net Income peaked at -$22.9 million in Q1 2021 and troughed at -$130.1 million in Q3 2025.
  • A 5-year average of -$62.1 million and a median of -$53.4 million in 2023 define the central range for Net Income.
  • Biggest five-year swings in Net Income: fell 20.23% in 2023 and later tumbled 69.33% in 2025.
  • Year by year, Net Income stood at -$30.8 million in 2021, then plummeted by 48.18% to -$45.7 million in 2022, then fell by 22.53% to -$55.9 million in 2023, then plummeted by 44.08% to -$80.6 million in 2024, then plummeted by 52.16% to -$122.6 million in 2025.
  • Business Quant data shows Net Income for CRNX at -$122.6 million in Q4 2025, -$130.1 million in Q3 2025, and -$115.7 million in Q2 2025.